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Abstract
Background: Most HIV infected patients will develop some sort of neurologic involvement of the disease
throughout their lives, usually in advanced stages. Neurologic symptoms may occur in acute HIV infection but
myelopathy in this setting is rare. Up until this date, only two cases of transverse myelitis as a manifestation of
acute HIV infection have been reported in the literature. Therapeutic approach in these patients is not well defined.
Case presentation: A 35 year-old male Caucasian recently returned from the tropics presented to our hospital with
urinary retention and acute paraparesis. After extensive diagnostic workup he was diagnosed with acute HIV
infection presenting as transverse myelitis. Full neurologic recovery was observed without the use of anti-retroviral
therapy.
Conclusion: Acute spinal cord disorders are challenging, as they present a wide array of differential diagnosis and
may lead to devastating sequelae. Timely and rigorous diagnostic workup is of the utmost importance when
managing these cases. Clinicians should be aware of the protean manifestations of acute HIV infection, including
central nervous system involvement, and have a low threshold for HIV screening.
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Background
HIV-associated neurological syndromes are diverse and
usually diagnosed at advanced stages of the disease [1].
However, neurological involvement can also occur at early
stages of the infection, making the diagnosis challenging
[2-4]. In tropical areas the differential diagnosis of neuro-
logical disorders is particularly difficult, as a broad range
of infectious causes need to be considered. We report a
case of an acute HIV infection presenting as transverse
myelitis in a patient returning from sub-Saharan Africa.
The diagnostic approaches of acute spinal cord disorders
are also reviewed.
Case presentation
A 35-year-old Caucasian male presented to an Emergency
Room of a Portuguese tertiary care hospital with urinary
retention and diminished strength in the lower limbs. He
had returned a week before from Angola where he had
been working as a construction worker for the past
10 months (Table 1). He had been vaccinated for yellow
fever, poliomyelitis, typhoid fever and meningococcal dis-
ease in advance. Excluding an episode of malaria soon
after his arrival to Angola, he was asymptomatic until
6 weeks before returning home to Portugal, when he and
other co-workers had an acute onset of fever, vomiting
and diarrhoea after sharing a meal. Over the following
days, while he was still recovering, he woke up suddenly
with pain in the umbilical area where he noticed three red
spotted lesions that became enlarged and necrotic. He was
told by a medical doctor that he had most likely been bit-
ten by a spider and was treated with local dressings and
analgesia, with improvement. One week later he developed
fever, non productive cough, progressive dyspnoea and
thoracic pain that he described as bilateral, oppressive and
“belt-like”. Additionally, generalised myalgia and fatigue
gradually installed. He was treated in a local clinic with an-
tibiotics without resolution of symptoms. Unable to work,
he returned to Portugal and visited another hospital in the
same day for persisting fatigue and thoracic pain. Inflam-
matory parameters were not elevated and chest roentgen-
ography was normal. He was sent home on analgesics. Six
days later he presented to our tertiary care hospital* Correspondence: andrade.pf@gmail.com
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complaining of worsening fatigue, thoracic pain and urin-
ary retention.
Past medical history was irrelevant. The patient denied
unprotected sexual contacts in the past ten months, intra-
venous drug use, blood transfusions or past surgical pro-
cedures. He had performed an ear piercing two months
before in Angola.
On admission the patient was afebrile. Blood pressure
was 124/68 mmHg, his pulse was regular with 80 beats
per minute and respirations 14 breaths per minute.
Neurological examination revealed diminished motor
strength in lower extremities (grade 3/5), reduced tact-
ile and pain sensations below L1, normal deep tendon
reflexes and bilateral indifferent plantar responses. No
cognitive dysfunction or neck rigidity was noticed. Oph-
thalmologic and cranial nerves examination was nor-
mal. A periumbilical triangular scar was observed, with
no inflammatory signs. The remainder of physical examin-
ation was unremarkable.
Routine laboratory data was normal, including complete
blood count (Hb 15.6 g/dL, WBC 9.07 × 109/L with 81%
neutrophils, platelets 325 × 109/L), renal and liver function
tests. Thick blood smear and rapid diagnostic test for mal-
aria were negative. HIV test (4th generation ELISA) was
positive and Inno-Lia™ test was indeterminate (positive
gp41 band). Chest roentgenography was normal. Cerebro-
spinal fluid (CSF) examination revealed 302 leukocytes/μL,
glucose 0.56 g/L and protein content 0.74 g/L. Gram stain
was negative. Magnetic Resonance Imaging (MRI) of the
brain was normal, but MRI of the medulla showed ex-
tensive hyperintense signal in the long TR sequence
throughout C4 to T11, especially in the posterior columns,
suggesting inflammatory/infectious aetiology (Figure 1).
He was admitted with a diagnosis of acute transverse
myelitis and treatment with ceftriaxone (2 g IV bid), ganci-
clovir (400 mg IV tid) and methylprednisolone (1 g IV qd
for 3 days and then tapered to 1 mg/Kg/d) was started.
Over the two following days his clinical condition deteri-
orated, with intensifying upper thoracic pain, progressing
hypoaesthesia up to T10 and dysaesthesia becoming more
disabling and characterised by numbness and ice cold sen-
sation. Constipation and urinary retention were also
present.
A second lumbar puncture performed at day 3 re-
vealed 15 leucocytes/μL, glucose 0.98 g/L and protein
content 0.86 g/L. India ink stain was negative.
Doxycicline (100 mg bid) and human immunoglobulin
(30 gr IV qd) were associated at this point. Ganciclovir
was discontinued after negative CMV results (Table 1).
Significant improvement was observed within the next
days and one week later the patient was able to walk un-
assisted, with complete resolution of dysaesthesia, urinary
retention and constipation. Three weeks after admission
he was discharged home asymptomatic, having completed
21d of ceftriaxone, 7d of methylprednisolone, 7d of doxy-
cicline and 5d of human immunoglobulin.
HIV testing was repeated before discharge: 4th gener-
ation ELISA was positive and Inno-Lia™ remained indeter-
minate (positive gp41 band). All cultures were negative, as
well as several serology and PCR-based technique tests
(Table 2). Convalescent titters were repeated for Borrelia,
Rickettsia conorii, West Nile Virus and Dengue, all nega-
tive. HIV-1, subtype K RNA copies were quantified in
blood and CSF: 743.000 and 77.700 cp/mL respectively. By
the time these results were known the patient was already
improving significantly and no antiretroviral therapy was
started. His CD4 count was 408/mm3 on admission and
760/mm3 in a second determination before discharge.
Three months later the patient presented to the out-
patient clinic and was asymptomatic. HIV Inno-Lia™ test
was then positive (positive p17, p24, p31, gp41 and gp120).
Table 1 Timeline of the main clinical events
PRIOR TO HOSPITAL ADMISSION
Week 1 Travels to Angola.
Week 4 Uncomplicated malaria episode.
Week 32 Ear piercing.
Week 34 Probable gastroenteritis and arthropod bite.
Week 35 Fatigue, fever, myalgia, non-productive cough,
thoracic pain (belt-like).
Treated with antibiotics.
Week 40 Persisting fatigue and thoracic pain.
Returns to Portugal and seeks medical care.
Discharged on analgesics.
HOSPITAL ADMISSION
Day 1 Worsening fatigue and thoracic pain.
Urinary retention, paraparesia and hypoaesthesia.
HIV screening positive, Inno-Lia™ indeterminate.
MRI suggestive of myelitis.
Ceftriaxone, gancyclovir and methylprednisolone.
Day 3 Worsening neurologic symptoms.
Mild CSF pleocytosis and protein elevation.
Doxycicline and human immunoglobulin. Stops gancyclovir.
Day 10 Progressive and complete resolution of symptoms.
HIV-1 RNA detection on blood and CSF. 760/mm3 T-CD4 count.






Progressive decline of T-CD4 count to below 400/mm3.
Anti-retroviral therapy instituted.
CSF: cerebrospinal fluid; MRI: magnetic resonance imaging.
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He repeated a medullar MRI 8 weeks after discharge: previ-
ous findings had resolved completely and no pathological
changes were found.
After one year of follow up he continued asymptom-
atic but with a CD4 count decline to below 400/mm3
his viral load had stabilized around 130.000 cp/mL. He
started highly active anti-retroviral therapy (HAART)
with abacavir/lamivudine and efavirenz, and 6 months
later he had undetectable viral load with increased CD4+
cell count.
Conclusion
Differential diagnosis of an evolving myelopathy is broad
and might include compressive, vascular, immune-mediated
Figure 1 Axial and sagittal T2-weighted magnetic resonance images. Bilateral and symmetrical T2 hyperintensity in the thoracic spinal cord,
extending from D2 to D11, predominantly involving the posterior columns. No swelling, atrophy or enhancement were present. Although not
specific, these findings might be consistent with HIV myelopathy.
Table 2 Main laboratory results for diagnostic workup




HSV 1&2, H-6, CMV, EBV, VZV,
Enterovirus, WNV, JCV, HTLV1,
Rickettsia spp, Borrelia spp,
M. pneumoniae, L. monocytogenes,
MTC all negative
VDRL, FTA-ABS all negative Malignant cells negative,
immunoelectrophoresis normal,
India ink stain negative
HIV-1 (77.700 cp/mL)
Blood Bacteria and fungi
all negative
CMV negative VDRL, TPPA/TP, Borrelia spp,
Rickettsia conorii, HSV 1&2, EBV,
Dengue, WNV all negative
CMV antigen negative
HIV-1 (743.000 cp/mL) CMV, T. gondii
(IgM negative, IgG positive)
T-CD4 cell count (408/mm3)
HIV (ELISA positive, Inno-Lia™
indeterminate with
positive gp41 band)
CMV: cytomegalovirus; CSF: cerebrospinal fluid; EBV: Epstein-Barr virus; H-6: Herpes 6 virus; HSV: Herpes simplex virus; HTLV1: human T lymphotropic virus Type 1;
JCV: JC virus; MTC: Mycobacterium tuberculosis complex; PCR: polymerase chain reaction; VZV: Varicella-Zoster virus; WNV: West Nile Virus.
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and infectious aetiologies. Initial evaluation with appro-
priate imaging should focus on excluding compressive
aetiology for which urgent neurosurgical evaluation is
mandatory [5]. MRI with gadolinium contrast agent
should therefore be obtained in a short-time period. If
no compressive cause is identified, a lumbar puncture
should be performed to distinguish an inflammatory
from a non-inflammatory condition (such as ischemia,
epidural lipomatosis or fibrocartilagineous embolism).
Precipitous onset of symptoms (usually reaching max-
imal severity in < 4 h), absence of pleocytosis in CSF and
no gadolinium enhancement on spinal cord MRI are
highly suggestive of vascular causes [6]. If an inflamma-
tory myelopathy is identified further evaluation should
be undertaken. Clinical features, laboratory studies and
imaging findings provide useful information for neuro-
logical conditions such as multiple sclerosis, neuromy-
elitis optica and systemic inflammatory diseases such as
systemic lupus erythematosus, sarcoidosis and Sjögren
Syndrome [6]. Nonetheless, infections are thought to be re-
sponsible for most cases of myelitis. Virus, bacteria, fungi
or parasites might cause central nervous system (CNS) in-
jury, either due to direct cytolytic effects or through sec-
ondary immune mediated processes. Acute disseminated
encephalomyelitis (ADEM) is a monophasic inflammatory
demyelinating disorder that can follow an infectious dis-
ease or vaccination. Unlike Guillain-Barré syndrome, that
affects peripheral nerves, ADEM involves the CNS and
therefore should also be considered [6].
Treatment of myelitis should be tailored to the individ-
ual patient. Antibiotics, antivirals, high doses of corticoste-
roids and intravenous immunoglobulin have been used,
but evidence on the efficacy of most strategies is lacking.
Our patient presented several diagnostic challenges.
Compressive causes had been excluded by early MRI.
Acute transverse myelitis (ATM) diagnosis was supported
by acute paraparesis with bilateral sensory findings, im-
paired sphincter function, the presence of spinal segmen-
tal level of sensory disturbance and the evidence of
inflammation within the spinal cord demonstrated by CSF
pleocytosis. Given the wide range of possible causes for
ATM and taking into account the particular details of our
patient history we were confronted with a wide range of
challenging hypothesis: are we facing post-infectious mye-
litis secondary to acute gastroenteritis? Is this a toxin me-
diated myelitis caused by spider or snake venom? What if
the periumbilical skin lesion is a tick bite sequelae, and
Borrelia or Rickettsia sp are implicated? What about viral
myelitis, the most common aetiology for ATM? Shouldn’t
we consider viruses that can cause myelitis worldwide
(Herpes viruses, Enterovirus) but also those than can be
present in Africa (Dengue, West Nile virus, HTLV1)? Fi-
nally, how should we value a positive HIV screening test
when no high risk exposure is identified? Could it be a
false positive in the setting of another viral illness? Or
could myelitis be the presentation of an acute retroviral
syndrome?
It is estimated that in 40 to 70 percent of HIV-1–in-
fected people neurologic complications will develop [7].
Viral infection can directly affect the central and periph-
eral nervous systems or lead to increased susceptibility to
opportunistic infections due to immunodeficiency [8]. Dir-
ect CNS involvement most commonly presents as a HIV
encephalitis, HIV leucoencephalopathy, vacuolar leucoen-
cephalopathy or vacuolar myelopathy. CNS opportunistic
infections to be considered include toxoplasmosis, crypto-
coccosis, tuberculosis and viral encephalitis such as CMV,
among others [9]. Although less common, neurological
manifestations can occur at early stages of HIV infection.
These include peripheral neuropathy, radiculopathy,
facial palsy and Guillain-Barré syndrome [2-4]. In rare
cases, CNS may be predominantly affected, and acute
or subacute transverse myelitis may be the presenting
manifestation of HIV. Overall, ATM is an uncommon
disease, with an estimated incidence of 3.1 cases per
100.000 patient years [10]. Classic symptomatic acute
HIV infection is characterized by a mononucleosis-like
syndrome, with fever, lymph node enlargement, pha-
ryngitis, maculo-papular rash, myalgia an arthralgia;
thrombocytopenia and leukopenia are common labora-
tory findings. In this setting, ATM is exceedingly rare,
with only two cases previously reported [11,12]. Ste-
roids and immunoglobulin are usually recommended
for treatment and in the context of retroviral infection
ARV therapy is likely beneficial, based on theoretical
grounds. In one reported case, in the pre-HAART era,
partial improvement with neurologic sequelae was ob-
served [11]. In another, HAART and corticosteroids
seemed beneficial, ensuring full recovery [12]. In our
particular case, HIV infection wasn’t the most likely
diagnosis at admission, given the absence of previous
high risk exposure and the presence of more plausible
alternative hypothesis. Therefore, the patient received
a combination of anti-inflammatory and antimicrobial
drugs and complete clinical and imagiological reso-
lution was documented. The fact that by the time HIV
infection was confirmed the patient was already recov-
ering supported our decision of not starting ARV then.
We described a very rare case of acute HIV infection
presenting as ATM in a patient where the suspicion index
for HIV infection was rather low. The long list of alterna-
tive causes led to a particularly elusive diagnosis. Diagnosis
of transverse myelitis following acute HIV infection was
made after excluding other aetiologies. Our patient also
illustrates a unique case of complete recovery without
HAART. This report highlights the large spectrum of clin-
ical presentations an acute HIV infection might have and
the need for a low threshold for HIV screening.
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